<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1307" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1307/" /><meta name="ncbi_pagename" content="BSCL2-Related Neurologic Disorders/Seipinopathy - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>BSCL2-Related Neurologic Disorders/Seipinopathy - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="BSCL2-Related Neurologic Disorders/Seipinopathy" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/05/24" /><meta name="citation_author" content="Daisuke Ito" /><meta name="citation_pmid" content="20301484" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1307/" /><meta name="citation_keywords" content="Spastic Paraplegia 17" /><meta name="citation_keywords" content="Silver Syndrome" /><meta name="citation_keywords" content="Distal Hereditary Motor Neuropathy Type V (dHMN-V)" /><meta name="citation_keywords" content="Variants of Charcot-Marie-Tooth Disease Type 2" /><meta name="citation_keywords" content="Seipin" /><meta name="citation_keywords" content="BSCL2" /><meta name="citation_keywords" content="BSCL2-Related Neurologic Disorders/Seipinopathy" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="BSCL2-Related Neurologic Disorders/Seipinopathy" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Daisuke Ito" /><meta name="DC.Date" content="2018/05/24" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1307/" /><meta name="description" content="The spectrum of BSCL2-related neurologic disorders includes Silver syndrome and variants of Charcot-Marie-Tooth neuropathy type 2, distal hereditary motor neuropathy (dHMN) type V, and spastic paraplegia 17. Features of these disorders include onset of symptoms ranging from the first to the seventh decade, slow disease progression, upper motor neuron involvement (gait disturbance with pyramidal signs ranging from mild to severe spasticity with hyperreflexia in the lower limbs and variable extensor plantar responses), lower motor neuron involvement (amyotrophy of the peroneal muscles and small muscles of the hand), and pes cavus and other foot deformities. Disease severity is variable among and within families." /><meta name="og:title" content="BSCL2-Related Neurologic Disorders/Seipinopathy" /><meta name="og:type" content="book" /><meta name="og:description" content="The spectrum of BSCL2-related neurologic disorders includes Silver syndrome and variants of Charcot-Marie-Tooth neuropathy type 2, distal hereditary motor neuropathy (dHMN) type V, and spastic paraplegia 17. Features of these disorders include onset of symptoms ranging from the first to the seventh decade, slow disease progression, upper motor neuron involvement (gait disturbance with pyramidal signs ranging from mild to severe spasticity with hyperreflexia in the lower limbs and variable extensor plantar responses), lower motor neuron involvement (amyotrophy of the peroneal muscles and small muscles of the hand), and pes cavus and other foot deformities. Disease severity is variable among and within families." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1307/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/spg17/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1307/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8A91A7E040B53100000000029000F0.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1307_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1307_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/brca1/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/bgs/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1307_"><span class="title" itemprop="name"><i>BSCL2</i>-Related Neurologic Disorders/Seipinopathy</span></h1><p class="contrib-group"><span itemprop="author">Daisuke Ito</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1307_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1307_ai__"><div class="contrib half_rhythm"><span itemprop="author">Daisuke Ito</span>, MD, PhD<div class="affiliation small">Department of Neurology<br />School of Medicine<br />Keio University<br />Tokyo, Japan<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="pj.en.ten-os.9kj@oti-d" class="oemail">pj.en.ten-os.9kj@oti-d</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">December 6, 2005</span>; Last Update: <span itemprop="dateModified">May 24, 2018</span>.</p><p><em>Estimated reading time: 16 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="spg17.Summary" itemprop="description"><h2 id="_spg17_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>The spectrum of <i>BSCL2</i>-related neurologic disorders includes Silver syndrome and variants of Charcot-Marie-Tooth neuropathy type 2, distal hereditary motor neuropathy (dHMN) type V, and spastic paraplegia 17. Features of these disorders include onset of symptoms ranging from the first to the seventh decade, slow disease progression, upper motor neuron involvement (gait disturbance with pyramidal signs ranging from mild to severe spasticity with hyperreflexia in the lower limbs and variable extensor plantar responses), lower motor neuron involvement (amyotrophy of the peroneal muscles and small muscles of the hand), and <i>pes cavus</i> and other foot deformities. Disease severity is variable among and within families.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of a <i>BSCL2</i>-related neurologic disorder is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with characteristic clinical and electrophysiologic features and identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>BSCL2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Symptomatic treatment includes physiotherapy, orthopedic shoes, and calipers to stabilize gait. Foot deformities may be corrected with surgery.</p><p><i>Prevention of secondary complications:</i> Early regular physiotherapy may prevent contractures.</p><p><i>Surveillance</i>: Annual evaluation of gait, strength, muscular atrophy, and deep tendon reflexes by a neurologist.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>BSCL2</i>-related neurologic disorders are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Each child of an individual with a <i>BSCL2</i>-related neurologic disorder has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Penetrance is incomplete, with more than 20% of individuals with the pathogenic variant showing no clinical abnormalities or only minor clinical signs. Prenatal testing for pregnancies at increased risk is possible in families in which the pathogenic variant is known; however, requests for prenatal testing for adult-onset disorders are not common.</p></div></div><div id="spg17.GeneReview_Scope"><h2 id="_spg17_GeneReview_Scope_">GeneReview Scope</h2><div id="spg17.Tc" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1307/table/spg17.Tc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__spg17.Tc_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_spg17.Tc_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><i>BSCL2</i>-Related Neurologic Disorders/Seipinopathy: Included Phenotypes&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_spg17.Tc_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Distal hereditary motor neuropathy type V (dHMN-V)</div></li><li class="half_rhythm"><div>Silver syndrome</div></li><li class="half_rhythm"><div>Variants of Charcot-Marie-Tooth disease type 2</div></li><li class="half_rhythm"><div>Spastic paraplegia 17</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="spg17.TF.c.1"><p class="no_margin">For other genetic causes of these phenotypes see <a href="#spg17.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="spg17.Diagnosis"><h2 id="_spg17_Diagnosis_">Diagnosis</h2><p>The phenotypic spectrum of <i>BSCL2</i>-related neurologic disorders includes Silver syndrome and variants of Charcot-Marie-Tooth disease type 2, distal hereditary motor neuropathy (dHMN) type V, and spastic paraplegia 17.</p><div id="spg17.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>BSCL2</i>-related neurologic disorders <b>should be suspected</b> in individuals with the following clinical and electrophysiologic features.</p><p><b>Clinical features</b></p><ul><li class="half_rhythm"><div>Onset of symptoms from the first to the seventh decade (range: age 6-66 years; mean: age 19 years)</div></li><li class="half_rhythm"><div>Slow disease progression</div></li><li class="half_rhythm"><div>Upper motor neuron involvement: gait disturbance with pyramidal signs ranging from mild to severe spasticity with hyperreflexia in the lower limbs and variable extensor plantar responses</div></li><li class="half_rhythm"><div>Lower motor neuron involvement: amyotrophy (wasting) of the peroneal muscles and the small muscles of the hand (particularly the thenar and 1st dorsal interosseus muscles) that is frequently unilateral</div></li><li class="half_rhythm"><div>Paresthesia, sensory loss, and sphincter disturbances usually absent</div></li><li class="half_rhythm"><div><i>Pes cavus</i> and other foot deformities</div></li></ul><p><b>Electrophysiologic features</b></p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Reduced compound motor action potentials (CMAP)</b> in the lower limbs indicate primarily axonal nerve damage. Marked chronodispersion of the CMAP is found.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Motor nerve conduction velocities (MNCV)</b> are sometimes in the demyelinating range (&#x0003c;37 m/sec) pointing to additional demyelination of the peripheral nerves. Partial conduction blocks may occur.</div><div class="half_rhythm">Note: In the upper limbs, changes of the MNCV and CMAP are more frequently seen in the median nerve than in the ulnar nerve.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Median and sural sensory nerve conduction velocities (SNCV)</b> do not show significant changes, but reduction of the sensory nerve action potentials (SNAP) in individuals with advanced disease strongly suggests that <i>BSCL2</i> pathogenic variants also lead to axonal damage of the sensory nerves.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Electromyography</b> usually reveals chronic neurogenic disturbance with high potential amplitudes [<a class="bk_pop" href="#spg17.REF.auergrumbach.2000.1612">Auer-Grumbach et al 2000</a>].</div></li></ul></div><div id="spg17.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>BSCL2</i>-related neurologic disorders <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the above <a href="#spg17.Suggestive_Findings">Suggestive Findings</a> and identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>BSCL2</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1307/table/spg17.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figspg17Tmoleculargenetictestingusedi" rid-ob="figobspg17Tmoleculargenetictestingusedi">Table 1</a>).</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of <i>BSCL2</i>-related neurologic disorders is broad, individuals with the distinctive findings described in <a href="#spg17.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#spg17.Option_1">Option 1</a>), whereas those in whom the diagnosis of <i>BSCL2</i>-related neurologic disorders has not been considered are more likely to be diagnosed using genomic testing (see <a href="#spg17.Option_2">Option 2</a>).</p><div id="spg17.Option_1"><h4>Option 1</h4><p>When the phenotypic and laboratory findings suggest the diagnosis of <i>BSCL2</i>-related neurologic disorders, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>BSCL2</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected. Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> first. If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, perform gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications.</div><div class="half_rhythm">Note: All reported pathogenic variants (<a class="figpopup" href="/books/NBK1307/table/spg17.T.bscl2_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figspg17Tbscl2variantsdiscussedinthis" rid-ob="figobspg17Tbscl2variantsdiscussedinthis">p.Asn88Ser</a>, <a class="figpopup" href="/books/NBK1307/table/spg17.T.bscl2_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figspg17Tbscl2variantsdiscussedinthis" rid-ob="figobspg17Tbscl2variantsdiscussedinthis">p.Ser90Leu</a>, and <a class="figpopup" href="/books/NBK1307/table/spg17.T.bscl2_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figspg17Tbscl2variantsdiscussedinthis" rid-ob="figobspg17Tbscl2variantsdiscussedinthis">p.Ser90Trp</a>) reside in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 3; therefore, <b>targeted analysis</b> can be performed first by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>BSCL2</i> exon 3.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>BSCL2</i> and other genes of interest (see <a href="#spg17.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul></div><div id="spg17.Option_2"><h4>Option 2</h4><p>When the diagnosis of <i>BSCL2</i>-related neurologic disorders is not considered because an individual has atypical phenotypic features, comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. Exome sequencing is most commonly used; <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> is also possible.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="spg17.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in BSCL2-Related Neurologic Disorders/Seipinopathy</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1307/table/spg17.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__spg17.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_spg17.T.molecular_genetic_testing_used_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_spg17.T.molecular_genetic_testing_used_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_spg17.T.molecular_genetic_testing_used_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_spg17.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>BSCL2</i></td><td headers="hd_h_spg17.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_spg17.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_spg17.T.molecular_genetic_testing_used_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_spg17.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown; none reported</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="spg17.TF.1.1"><p class="no_margin">See <a href="/books/NBK1307/#spg17.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="spg17.TF.1.2"><p class="no_margin">See <a href="#spg17.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="spg17.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="spg17.TF.1.4"><p class="no_margin">Because this disorder is defined by the presence of a causative <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>BSCL2</i>, the variant detection rate is expected to be 100%; the rate would be less if any deletions/duplications were found to cause the disorder.</p></div></dd><dt>5. </dt><dd><div id="spg17.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd></dl></div></div></div></div></div></div><div id="spg17.Clinical_Characteristics"><h2 id="_spg17_Clinical_Characteristics_">Clinical Characteristics</h2><div id="spg17.Clinical_Description"><h3>Clinical Description</h3><p><i>BSCL2</i>-related neurologic disorders affect both the lower and upper motor neurons. Detailed clinical and electrophysiologic studies in 90 individuals with the <a class="figpopup" href="/books/NBK1307/table/spg17.T.bscl2_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figspg17Tbscl2variantsdiscussedinthis" rid-ob="figobspg17Tbscl2variantsdiscussedinthis">p.Asn88Ser</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> showed incomplete <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, clinical <a class="def" href="/books/n/gene/glossary/def-item/intrafamilial-variability/">intrafamilial variability</a> with several phenotypic subtypes being reported (even within the same family), and broad variation in disease severity, suggesting a subdivision into the following six main phenotypes (<b>subtypes 1-6</b>), all of which can be seen in the same family [<a class="bk_pop" href="#spg17.REF.auergrumbach.2005.415">Auer-Grumbach et al 2005</a>].</p><p><b>Subtype 1.</b> No signs or symptoms. No clinical or electrophysiologic abnormalities are present.</p><p><b>Subtype 2.</b> Clinical signs but no symptoms. Suggestive clinical signs include foot deformity, mild asymmetric thenar wasting, brisk lower-limb deep-tendon reflexes (DTRs), and/or electrophysiologic abnormalities.</p><p><b>Subtype 3.</b> Distal hereditary motor neuropathy (dHMN) type V <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Symptoms are exclusively or predominantly symmetric or unilateral muscle weakness and wasting in the small muscles of the hand. Gait disturbances may occur later. Muscle tone is normal; tendon reflexes may be preserved or slightly brisk.</p><p><b>Subtype 4.</b> Silver syndrome <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#spg17.REF.silver.1966.69">Silver 1966</a>]. Findings are mild-to-severe symmetric or unilateral amyotrophy of the small muscles of the hand, variable spasticity of the lower limbs, and other signs of pyramidal tract disturbance (very brisk tendon reflexes and/or extensor plantar responses and/or increased muscle tone).</p><p><b>Subtype 5.</b> Charcot-Marie-Tooth neuropathy type 2 (spinal CMT) <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Findings are distal muscle weakness and wasting of the lower limbs and, to a lesser degree, of the upper limbs. Muscle tone is normal and tendon reflexes are usually preserved or slightly brisk. Depending on the absence or presence of clinical and electrophysiologic sensory abnormalities, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may show spinal CMT syndrome or hereditary motor and sensory neuropathy (HMSN) type II.</p><p><b>Subtype 6.</b> Hereditary spastic paraplegia (HSP) <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Findings include: absence of weakness or wasting of the small hand muscles; and presence of spastic paraparesis in the lower limbs manifesting as EITHER of the following:</p><ul><li class="half_rhythm"><div>Pure hereditary spastic paraparesis (pHSP) when no additional clinical or electrophysiologic features (except foot deformity) are present</div></li><li class="half_rhythm"><div>Complicated hereditary spastic paraparesis (cHSP) when spasticity is accompanied by amyotrophy of the distal muscles of the legs and/or pathologic nerve conduction velocities. This latter group may also be diagnosed as hereditary motor and sensory neuropathy (HMSN) type V.</div></li></ul><p><b>Onset.</b> Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals develop symptoms in the second decade of life, but some first notice symptoms as late as the seventh decade. Only a few persons have signs before age ten years. In some individuals with mild disease, the age at onset cannot be determined as they are not aware of being affected.</p><p><b>Tendon reflexes</b> are normal in the upper extremities. Patellar and Achilles tendon reflexes are rarely absent or diminished. Most individuals have preserved or even brisk reflexes, which correspond to increased muscle tone.</p><p>Affected individuals often present with other signs of pyramidal tract involvement such as extensor plantar responses. Individuals with spasticity in the lower limbs often complain of leg stiffness and muscle cramps.</p><p><b>Hand muscle involvement</b> is a major feature. Weakness that is often more evident in one hand than the other and wasting of the thenar and first dorsal interosseus muscles often result in a characteristic adduction position of the thumb and difficulty with handwriting. In advanced stages of the disease, camptodactyly (fixed flexion deformity of the fingers) can be a significant finding in some, but not all, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. The predilection for these two muscle groups and the left-right asymmetry (which does not correlate with handedness in the affected individual) remain unexplained.</p><p><b>Gait.</b> Mild-to-severe gait abnormalities are often observed and result from EITHER or BOTH of the following:</p><ul><li class="half_rhythm"><div>Wasting and weakness of the distal muscles of the lower limbs leading to a steppage gait</div></li><li class="half_rhythm"><div>Stiffness and spasticity</div></li></ul><p><b>Foot deformity</b> is present in the majority of individuals and may vary from mild to severe <i>pes cavus</i>, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> <i>pes planus</i>, hammertoes, or clubfeet.</p><p><b>Prognosis.</b> Disease progression is slow. People with this disorder have a generally normal life expectancy.</p><p><b>Histopathology.</b> Sural nerve biopsy shows mild loss of myelinated fibers and fiber regeneration [<a class="bk_pop" href="#spg17.REF.chen.2009.543">Chen et al 2009</a>, <a class="bk_pop" href="#spg17.REF.luigetti.2010.448">Luigetti et al 2010</a>]. The diameter histogram shows a reduction in small fibers (diameter &#x0003c;10 &#x003bc;m).</p></div><div id="spg17.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Individuals with the <i>BSCL2</i> pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant <a class="figpopup" href="/books/NBK1307/table/spg17.T.bscl2_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figspg17Tbscl2variantsdiscussedinthis" rid-ob="figobspg17Tbscl2variantsdiscussedinthis">p.Asn88Ser</a> (in which the amino acid asparagine required for N-glycosylation is exchanged) usually remain ambulatory and active up to old age. In many individuals, the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is dominated by subtypes 2, 3, or 5 [<a class="bk_pop" href="#spg17.REF.auergrumbach.2000.1612">Auer-Grumbach et al 2000</a>].</p><p>Individuals with the <i>BSCL2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK1307/table/spg17.T.bscl2_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figspg17Tbscl2variantsdiscussedinthis" rid-ob="figobspg17Tbscl2variantsdiscussedinthis">p.Ser90Leu</a> exhibit more severe phenotypes (subtypes 4 and 6). Some of these individuals may become wheelchair bound during the second decade [<a class="bk_pop" href="#spg17.REF.irobi.2004.2124">Irobi et al 2004</a>].</p><p>Pathogenic variant <a class="figpopup" href="/books/NBK1307/table/spg17.T.bscl2_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figspg17Tbscl2variantsdiscussedinthis" rid-ob="figobspg17Tbscl2variantsdiscussedinthis">p.Ser90Trp</a>, which disrupts the N-glycosylation motif, was identified in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals from a Korean family with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> CMT type 2. These individuals had predominant hand involvement, pyramidal signs, and sensory loss. Notably, the majority of individuals (73%) complained of sensory loss, in which vibration sense was prominently impaired [<a class="bk_pop" href="#spg17.REF.choi.2013.35">Choi et al 2013</a>].</p><p>A variant of <a class="def" href="/books/n/gene/glossary/def-item/unknown-significance/">unknown significance</a> (<a class="figpopup" href="/books/NBK1307/table/spg17.T.bscl2_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figspg17Tbscl2variantsdiscussedinthis" rid-ob="figobspg17Tbscl2variantsdiscussedinthis">p.Arg96His</a>) that is not in the N-glycosylation motif was identified in an individual with <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> dHMN from a Taiwanese cohort. In vitro studies demonstrated that this variant results in the aggregation tendency of seipin protein, but does not induce endoplasmic reticulum stress, which is characteristically provoked by both <a class="figpopup" href="/books/NBK1307/table/spg17.T.bscl2_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figspg17Tbscl2variantsdiscussedinthis" rid-ob="figobspg17Tbscl2variantsdiscussedinthis">p.Asn88Ser</a> and <a class="figpopup" href="/books/NBK1307/table/spg17.T.bscl2_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figspg17Tbscl2variantsdiscussedinthis" rid-ob="figobspg17Tbscl2variantsdiscussedinthis">p.Ser90Leu</a> pathogenic variants [<a class="bk_pop" href="#spg17.REF.hsiao.2016.e0147677">Hsiao et al 2016</a>].</p><p>Note: (1) Pathogenic <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> variants in <i>BSCL2</i> are associated with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> <a href="/books/n/gene/bscl/">Berardinelli-Seip congenital lipodystrophy</a> (see <a href="#spg17.Genetically_Related_Allelic_Disord">Genetically Related Disorders</a>). (2) Exon 7 skipping due to <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> c.985C&#x0003e;T results in an early-onset progressive encephalopathy (see <a href="#spg17.Genetically_Related_Allelic_Disord">Genetically Related Disorders</a>).</p></div><div id="spg17.Penetrance"><h3>Penetrance</h3><p>Reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> for <i>BSCL2</i>-related neurologic disorders has been shown by <a class="bk_pop" href="#spg17.REF.patel.2001.209">Patel et al [2001]</a> and <a class="bk_pop" href="#spg17.REF.windpassinger.2003.99">Windpassinger et al [2003]</a>. A detailed <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation study in 90 individuals with the <a class="figpopup" href="/books/NBK1307/table/spg17.T.bscl2_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figspg17Tbscl2variantsdiscussedinthis" rid-ob="figobspg17Tbscl2variantsdiscussedinthis">p.Asn88Ser</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> demonstrated that 24.4% of individuals with the variant remained asymptomatic (subtype 1) or were only subclinically <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> (subtype 2) [<a class="bk_pop" href="#spg17.REF.auergrumbach.2005.415">Auer-Grumbach et al 2005</a>].</p></div><div id="spg17.Nomenclature"><h3>Nomenclature</h3><p>Silver syndrome was first described in 1966 in two British families [<a class="bk_pop" href="#spg17.REF.silver.1966.69">Silver 1966</a>].</p></div><div id="spg17.Prevalence"><h3>Prevalence</h3><p>The prevalence of <i>BSCL2</i>-related neurologic disorders/seipinopathy is unknown. To date, approximately 30 families worldwide with <i>BSCL2</i> pathogenic variants <a class="figpopup" href="/books/NBK1307/table/spg17.T.bscl2_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figspg17Tbscl2variantsdiscussedinthis" rid-ob="figobspg17Tbscl2variantsdiscussedinthis">p.Asn88Ser</a> and <a class="figpopup" href="/books/NBK1307/table/spg17.T.bscl2_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figspg17Tbscl2variantsdiscussedinthis" rid-ob="figobspg17Tbscl2variantsdiscussedinthis">p.Ser90Leu</a> have been identified and described [<a class="bk_pop" href="#spg17.REF.ito.2009.8">Ito &#x00026; Suzuki 2009</a>]. <a class="bk_pop" href="#spg17.REF.dierick.2008.1217">Dierick et al [2008]</a> carried out genetic analyses in a cohort of 112 individuals with a clinical diagnosis of dHMN and found that pathogenic variants in <i>BSCL2</i> are one of the most common causes of dHMN (7%) (see <a href="#spg17.Differential_Diagnosis">Differential Diagnosis</a>).</p></div></div><div id="spg17.Genetically_Related_Allelic_Disord"><h2 id="_spg17_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p>In addition to <i>BSCL2</i>-related neurologic disorders, the other <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> associated with pathogenic variants in <i>BSCL2</i> is <a href="/books/n/gene/bscl/">Berardinelli-Seip congenital lipodystrophy type 2</a>. Berardinelli-Seip <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> lipodystrophy (BSCL) type 1 and type 2, which are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner, are characterized by lipoatrophy affecting the trunk, limbs, and face; acromegaloid features; hepatomegaly; elevated serum concentration of triglycerides; and insulin resistance. Hypertrophic cardiomyopathy occurs in 20%-25% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and is a significant cause of morbidity and mortality. Notably, abnormality of motor neurons has not been reported in Berardinelli-Seip congenital lipodystrophy type 2.</p><p>Exon 7 skipping in <i>BSCL2</i> due to the c.985C&#x0003e;T <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> results in an aberrant isoform of seipin. This pathogenic variant is lethal in both homozygosity and compound heterozygosity with a <i>BSCL</i> type 2 pathogenic variant, resulting in an early-onset progressive encephalopathy (OMIM <a href="https://omim.org/entry/615924" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615924</a>).</p></div><div id="spg17.Differential_Diagnosis"><h2 id="_spg17_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Hereditary disorders to consider in the differential diagnosis for subtypes of <i>BSCL2</i>-related neurologic disorder.</b> Other types of axonal neuropathies (see <a href="/books/n/gene/cmt/">Charcot-Marie-Tooth Hereditary Neuropathy Overview</a>), variants of <a href="/books/n/gene/als-overview/">amyotrophic lateral sclerosis</a> (ALS), or <a href="/books/n/gene/hsp/">hereditary spastic paraplegia </a>may mimic <i>BSCL2</i>-related neurologic disorder subtypes:</p><ul><li class="half_rhythm"><div><b>Subtype 3.</b>
<a href="/books/n/gene/cmt2d/"><i>GARS1</i>-associated axonal neuropathy</a> caused by pathogenic variants in <i>GARS1</i> and inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner</div></li><li class="half_rhythm"><div><b>Subtype 4</b></div><ul><li class="half_rhythm"><div>ALS4 (juvenile-onset motor neuron disease) caused by pathogenic variants in <i>SETX</i> and inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner (see <a href="/books/n/gene/als-overview/">ALS Overview</a>)</div></li><li class="half_rhythm"><div>SPG3A, caused by pathogenic variants in <i>ATL1</i> and typically inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner</div></li></ul></li><li class="half_rhythm"><div><b>Subtype 5</b></div><ul><li class="half_rhythm"><div>Charcot-Marie-Tooth neuropathy type 2 (see <a href="/books/n/gene/cmt/">CMT Overview</a>)</div></li><li class="half_rhythm"><div>Spinal CMT (dHMN II) caused by pathogenic variants in <i>HSPB8</i> and inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner</div></li><li class="half_rhythm"><div>ALS4 (juvenile-onset motor neuron disease) caused by pathogenic variants in <i>SETX</i> and inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner (see <a href="/books/n/gene/als-overview/">ALS Overview</a>)</div></li></ul></li><li class="half_rhythm"><div><b>Subtype 6.</b> Genes responsible for pure and complicated <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> hereditary spastic paraplegia (see <a href="/books/n/gene/hsp/">Hereditary Spastic Paraplegia Overview</a>) and hereditary motor and sensory neuropathy type V (OMIM <a href="https://omim.org/entry/600361" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">600361</a>)</div></li></ul><p><b>Acquired disorders to consider in the differential diagnosis of <i>BSCL2</i>-related neurologic disorder</b></p><ul><li class="half_rhythm"><div>Acquired motor neuron disorders (e.g., multifocal motor neuropathy, amyotrophic lateral sclerosis)</div></li><li class="half_rhythm"><div>Entrapment syndromes of the upper extremities (e.g., carpal tunnel syndrome, compression of ulnar nerve)</div></li></ul></div><div id="spg17.Management"><h2 id="_spg17_Management_">Management</h2><div id="spg17.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <i>BSCL2</i>-related neurologic disorders, the evaluations summarized in this section (if not performed as part of the evaluation that led to the diagnosis) are recommended:</p><ul><li class="half_rhythm"><div>Physical examination to determine extent of weakness and atrophy, <i>pes cavus</i>, gait stability, and deep tendon reflex</div></li><li class="half_rhythm"><div>EMG with NCV</div></li><li class="half_rhythm"><div>Complete family history</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="spg17.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Treatment remains symptomatic and <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are often evaluated and managed by a multidisciplinary team that includes neurologists, physiatrists, orthopedic surgeons, clinical geneticists, and physical and occupational therapists.</p><p>Physiotherapy is appropriate.</p><p>Orthopedic treatment includes orthopedic shoes and calipers (polypropylene devices that fit between the thighs and hold the legs and hips in a balanced position for standing, used in conjunction with crutches or a walker) to stabilize gait. Foot deformities are corrected surgically.</p></div><div id="spg17.Prevention_of_Secondary_Complicati"><h3>Prevention of Secondary Complications</h3><p>Early regular physiotherapy can prevent contractures to a certain extent.</p></div><div id="spg17.Surveillance"><h3>Surveillance</h3><p>Annual neurologic evaluation of gait, strength, muscular atrophy, and deep tendon reflexes by a neurologist is appropriate.</p></div><div id="spg17.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#spg17.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="spg17.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="spg17.Genetic_Counseling"><h2 id="_spg17_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="spg17.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>BSCL2</i>-related neurologic disorders/seipinopathy are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="spg17.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Most individuals diagnosed with a <i>BSCL2</i>-related neurologic disorder have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with a <i>BSCL2</i>-related neurologic disorder may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The proportion of cases caused by <i>de novo</i> pathogenic variants is unknown.</div></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; evaluation may also include detailed clinical and electrophysiologic studies.</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with a <i>BSCL2</i>-related neurologic disorder may appear to be negative because of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. (Note: <i>BSCL2</i>-related neurologic disorders are characterized by clinical <a class="def" href="/books/n/gene/glossary/def-item/intrafamilial-variability/">intrafamilial variability</a>; several phenotypic subtypes may occur even within the same family.)</div></li><li class="half_rhythm"><div>If the parent is the individual in whom the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> first occurred, s/he may have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for the pathogenic variant and may be mildly/minimally <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the clinical/genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>/known to have the <i>BSCL2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, the risk to sibs of inheriting the pathogenic variant is 50%. However, <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> is incomplete and approximately 24% of individuals with pathogenic variants are asymptomatic.</div></li><li class="half_rhythm"><div>If the <i>BSCL2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the leukocyte DNA of either parent, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is estimated to be 1% because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#spg17.REF.rahbari.2016.126">Rahbari et al 2016</a>].</div></li><li class="half_rhythm"><div>If the parents have not been tested for the <i>BSCL2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> but are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low. However, sibs of a proband with clinically unaffected parents are still presumed to be at increased risk for a <i>BSCL2</i>-related neurologic disorder because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a parent or the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with a <i>BSCL2</i>-related neurologic disorder has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. However, <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> is incomplete and approximately 24% of individuals with pathogenic variants are asymptomatic.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members are at risk.</p></div><div id="spg17.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="spg17.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers in North America would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate. In Europe and other parts of the world, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> may be discouraged if treatment is not available.</p></div></div><div id="spg17.Resources"><h2 id="_spg17_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Institute of Neurological Disorders and Stroke (NINDS)</b></div><div>PO Box 5801</div><div>Bethesda MD 20824</div><div><b>Phone:</b> 800-352-9424 (toll-free); 301-496-5751; 301-468-5981 (TTY)</div><div><a href="https://www.ninds.nih.gov/Disorders/All-Disorders/Hereditary-Spastic-Paraplegia-Information-Page" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Hereditary Spastic Paraplegia Information Page</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=distalhereditarymotorneuropathytypev" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Distal hereditary motor neuropathy, type V</a></div></li><li class="half_rhythm"><div><b>Spastic Paraplegia Foundation, Inc.</b></div><div>7700 Leesburg Pike</div><div>Ste 123</div><div>Falls Church VA 22043</div><div><b>Phone:</b> 877-773-4483 (toll-free)</div><div><b>Email:</b> information@sp-foundation.org</div><div><a href="http://sp-foundation.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">sp-foundation.org</a></div></li></ul></div><div id="spg17.Molecular_Genetics"><h2 id="_spg17_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="spg17.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>BSCL2-Related Neurologic Disorders/Seipinopathy: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1307/table/spg17.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__spg17.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_spg17.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_spg17.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_spg17.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_spg17.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_spg17.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_spg17.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_spg17.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/26580" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>BSCL2</i></a></td><td headers="hd_b_spg17.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=26580" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">11q12<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_spg17.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q96G97" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Seipin</a></td><td headers="hd_b_spg17.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://reseq.biosciencedbc.jp/resequence/GeneDetail.do?targetId=9&#x00026;geneId=EG26580" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HSP mutation database (BSCL2)</a><br /><a href="http://www.molgen.ua.ac.be/CMTMutations/Mutations/Contexts.cfm?ID=31" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">IPN Mutations, BSCL2</a><br /><a href="http://databases.lovd.nl/shared/genes/BSCL2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">BSCL2 database</a></td><td headers="hd_b_spg17.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=BSCL2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">BSCL2</a></td><td headers="hd_b_spg17.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=BSCL2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">BSCL2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="spg17.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="spg17.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for BSCL2-Related Neurologic Disorders/Seipinopathy (<a href="/omim/270685,600794,606158,615924" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1307/table/spg17.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__spg17.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/270685" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">270685</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPASTIC PARAPLEGIA 17, AUTOSOMAL DOMINANT; SPG17</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600794" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600794</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VA; HMN5A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606158" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606158</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">BSCL2 GENE; BSCL2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615924" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615924</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>BSCL2</i> has 11 exons spanning approximately 17 kb of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1307/#spg17.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> To date, three pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants have been detected in individuals with <i>BSCL2</i>-related neurologic disorders (see <a class="figpopup" href="/books/NBK1307/table/spg17.T.bscl2_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figspg17Tbscl2variantsdiscussedinthis" rid-ob="figobspg17Tbscl2variantsdiscussedinthis">Table 2</a>). In addition, a variant of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, <a class="figpopup" href="/books/NBK1307/table/spg17.T.bscl2_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figspg17Tbscl2variantsdiscussedinthis" rid-ob="figobspg17Tbscl2variantsdiscussedinthis">p.Arg96His</a>, was reported in one Taiwanese individual with distal hereditary motor neuropathy.</p><p>Note: Exon 7 skipping due to <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> c.985C&#x0003e;T results in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> early-onset progressive encephalopathy (OMIM <a href="https://omim.org/entry/615924" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615924</a>). Other reported pathogenic variants, which include <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants, lead to <a href="/books/n/gene/bscl/">Berardinelli-Seip congenital lipodystrophy</a>, also an autosomal recessive disorder.</p><div id="spg17.T.bscl2_variants_discussed_in_this" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>BSCL2</i> Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1307/table/spg17.T.bscl2_variants_discussed_in_this/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__spg17.T.bscl2_variants_discussed_in_this_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_spg17.T.bscl2_variants_discussed_in_this_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_spg17.T.bscl2_variants_discussed_in_this_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_spg17.T.bscl2_variants_discussed_in_this_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_spg17.T.bscl2_variants_discussed_in_this_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.263A&#x0003e;G</td><td headers="hd_h_spg17.T.bscl2_variants_discussed_in_this_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn88Ser</td><td headers="hd_h_spg17.T.bscl2_variants_discussed_in_this_1_1_1_3" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_032667" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_032667<wbr style="display:inline-block"></wbr>​.6</a><br /><a href="/entrez/viewer.fcgi?val=NP_116056.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_116056<wbr style="display:inline-block"></wbr>​.3</a></td></tr><tr><td headers="hd_h_spg17.T.bscl2_variants_discussed_in_this_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.269C&#x0003e;T</td><td headers="hd_h_spg17.T.bscl2_variants_discussed_in_this_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser90Leu</td></tr><tr><td headers="hd_h_spg17.T.bscl2_variants_discussed_in_this_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.269C&#x0003e;G</td><td headers="hd_h_spg17.T.bscl2_variants_discussed_in_this_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser90Trp</td></tr><tr><td headers="hd_h_spg17.T.bscl2_variants_discussed_in_this_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.287G&#x0003e;A</td><td headers="hd_h_spg17.T.bscl2_variants_discussed_in_this_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg96His</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The function of seipin, a 398-amino acid residue integral membrane protein of the endoplasmic reticulum (ER), is regulation of adipocyte differentiation and lipid droplet formation [<a class="bk_pop" href="#spg17.REF.fei.2011.204">Fei et al 2011</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The p.Asn88Ser and p.Ser90Leu pathogenic variants disrupt the N-glycosylation motif and appear to result in proteins that are improperly folded. Furthermore, mutated proteins abnormally accumulate in the ER and eventually lead to cell death [<a class="bk_pop" href="#spg17.REF.ito.2007.237">Ito &#x00026; Suzuki 2007</a>]. The p.Asn88Ser seipin transgenic mice develop a progressive spastic motor deficit and neurogenic muscular atrophy, recapitulating the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of individuals with seipinopathy [<a class="bk_pop" href="#spg17.REF.yagi.2011.3831">Yagi et al 2011</a>].</p></div><div id="spg17.References"><h2 id="_spg17_References_">References</h2><div id="spg17.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="spg17.REF.auergrumbach.2000.1612">Auer-Grumbach M, Loscher WN, Wagner K, Petek E, Korner E, Offenbacher H, Hartung HP. Phenotypic and genotypic heterogeneity in hereditary motor neuronopathy type V: a clinical, electrophysiological and genetic study. <span><span class="ref-journal">Brain. </span>2000;<span class="ref-vol">123</span>:1612–23.</span> [<a href="/pubmed/10908191" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10908191</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg17.REF.auergrumbach.2005.415">Auer-Grumbach M, Schlotter-Weigel B, Lochmuller H, Strobl-Wildemann G, Auer-Grumbach P, Fischer R, Offenbacher H, Zwick EB, Robl T, Hartl G, Hartung HP, Wagner K, Windpassinger C. Phenotypes of the N88S Berardinelli-Seip congenital lipodystrophy 2 mutation. <span><span class="ref-journal">Ann Neurol. </span>2005;<span class="ref-vol">57</span>:415–24.</span> [<a href="/pubmed/15732094" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15732094</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg17.REF.chen.2009.543">Chen B, Zheng R, Luan X, Zhang W, Wang Z, Yuan Y. Clinical and pathological study of distal motor neuropathy with N88S mutation in BSCL2. <span><span class="ref-journal">Neuropathology. </span>2009;<span class="ref-vol">29</span>:543–7.</span> [<a href="/pubmed/19323790" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19323790</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg17.REF.choi.2013.35">Choi BO, Park MH, Chung KW, Woo HM, Koo H, Chung HK, Choi KG, Park KD, Lee HJ, Hyun YS, Koo SK. Clinical and histopathological study of Charcot-Marie-Tooth neuropathy with a novel S90W mutation in BSCL2. <span><span class="ref-journal">Neurogenetics. </span>2013;<span class="ref-vol">14</span>:35–42.</span> [<a href="/pubmed/23142943" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23142943</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg17.REF.dierick.2008.1217">Dierick I, Baets J, Irobi J, Jacobs A, De Vriendt E, Deconinck T, Merlini L, Van den Bergh P, Rasic VM, Robberecht W, Fischer D, Morales RJ, Mitrovic Z, Seeman P, Mazanec R, Kochanski A, Jordanova A, Auer-Grumbach M, Helderman-van den Enden AT, Wokke JH, Nelis E, De Jonghe P, Timmerman V. Relative contribution of mutations in genes for autosomal dominant distal hereditary motor neuropathies: a genotype-phenotype correlation study. <span><span class="ref-journal">Brain. </span>2008;<span class="ref-vol">131</span>:1217–27.</span> [<a href="/pubmed/18325928" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18325928</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg17.REF.fei.2011.204">Fei W, Du X, Yang H. Seipin, adipogenesis and lipid droplets. <span><span class="ref-journal">Trends Endocrinol Metab. </span>2011;<span class="ref-vol">22</span>:204–10.</span> [<a href="/pubmed/21497513" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21497513</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg17.REF.hsiao.2016.e0147677">Hsiao CT, Tsai PC, Lin CC, Liu YT, Huang YH, Liao YC, Huang HW, Lin KP, Soong BW, Lee YC. Clinical and molecular characterization of BSCL2 mutations in a Taiwanese cohort with hereditary neuropathy. <span><span class="ref-journal">PLoS One. </span>2016;<span class="ref-vol">11</span>:e0147677.</span> [<a href="/pmc/articles/PMC4729478/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4729478</span></a>] [<a href="/pubmed/26815532" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26815532</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg17.REF.irobi.2004.2124">Irobi J, Van den Bergh P, Merlini L, Verellen C, Van Maldergem L, Dierick I, Verpoorten N, Jordanova A, Windpassinger C, De Vriendt E, Van Gerwen V, Auer-Grumbach M, Wagner K, Timmerman V, De Jonghe P. The phenotype of motor neuropathies associated with BSCL2 mutations is broader than Silver syndrome and distal HMN type V. <span><span class="ref-journal">Brain. </span>2004;<span class="ref-vol">127</span>:2124–30.</span> [<a href="/pubmed/15242882" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15242882</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg17.REF.ito.2007.237">Ito D, Suzuki N. Molecular pathogenesis of seipin/BSCL2-related motor neuron diseases. <span><span class="ref-journal">Ann Neurol. </span>2007;<span class="ref-vol">61</span>:237–50.</span> [<a href="/pubmed/17387721" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17387721</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg17.REF.ito.2009.8">Ito D, Suzuki N. Seipinopathy: a novel endoplasmic reticulum stress-associated disease. <span><span class="ref-journal">Brain. </span>2009;<span class="ref-vol">132</span>:8–15.</span> [<a href="/pubmed/18790819" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18790819</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg17.REF.luigetti.2010.448">Luigetti M, Fabrizi GM, Madia F, Ferrarini M, Conte A, Delgrande A, Tonali PA, Sabatelli M. Seipin S90L mutation in an Italian family with CMT2/dHMN and pyramidal signs. <span><span class="ref-journal">Muscle Nerve. </span>2010;<span class="ref-vol">42</span>:448–51.</span> [<a href="/pubmed/20806400" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20806400</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg17.REF.patel.2001.209">Patel H, Hart PE, Warner TT, Houlston RS, Patton MA, Jeffery S, Crosby AH. The Silver syndrome variant of hereditary spastic paraplegia maps to chromosome 11q12-q14, with evidence for genetic heterogeneity within this subtype. <span><span class="ref-journal">Am J Hum Genet. </span>2001;<span class="ref-vol">69</span>:209–15.</span> [<a href="/pmc/articles/PMC1226036/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1226036</span></a>] [<a href="/pubmed/11389484" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11389484</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg17.REF.rahbari.2016.126">Rahbari R, Wuster A, Lindsay SJ, Hardwick RJ, Alexandrov LB, Turki SA, Dominiczak A, Morris A, Porteous D, Smith B, Stratton MR, Hurles ME, et al.  Timing, rates and spectra of human germline mutation. <span><span class="ref-journal">Nat Genet. </span>2016;<span class="ref-vol">48</span>:126–33.</span> [<a href="/pmc/articles/PMC4731925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4731925</span></a>] [<a href="/pubmed/26656846" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26656846</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg17.REF.silver.1966.69">Silver JR. Familial spastic paraplegia with amyotrophy of the hands. <span><span class="ref-journal">Ann Hum Genet. </span>1966;<span class="ref-vol">30</span>:69–75.</span> [<a href="/pubmed/5964029" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5964029</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg17.REF.windpassinger.2003.99">Windpassinger C, Wagner K, Petek E, Fischer R, Auer-Grumbach M. Refinement of the Silver syndrome locus on chromosome 11q12-q14 in four families and exclusion of eight candidate genes. <span><span class="ref-journal">Hum Genet. </span>2003;<span class="ref-vol">114</span>:99–109.</span> [<a href="/pubmed/13680364" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 13680364</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg17.REF.yagi.2011.3831">Yagi T, Ito D, Nihei Y, Ishihara T, Suzuki N. N88S seipin mutant transgenic mice develop features of seipinopathy/BSCL2-related motor neuron disease via endoplasmic reticulum stress. <span><span class="ref-journal">Hum Mol Genet. </span>2011;<span class="ref-vol">20</span>:3831–40.</span> [<a href="/pubmed/21750110" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21750110</span></a>]</div></li></ul></div></div><div id="spg17.Chapter_Notes"><h2 id="_spg17_Chapter_Notes_">Chapter Notes</h2><div id="spg17.Author_History"><h3>Author History</h3><p>Michaela Auer-Grumbach, MD; Medical University Graz (2005-2009)<br />Daisuke Ito, MD, PhD (2009-present)<br />Klaus Wagner, MD, PhD; Medical University Graz (2005-2009)</p></div><div id="spg17.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>24 May 2018 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>7 June 2012 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/targeted-mutation-analysis/">targeted mutation analysis</a> no longer offered clinically</div></li><li class="half_rhythm"><div>15 September 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>3 September 2009 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>6 December 2005 (me) Review posted live</div></li><li class="half_rhythm"><div>2 February 2005 (kw) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1307</span><span class="label">PMID: <a href="/pubmed/20301484" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301484</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/brca1/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/bgs/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1307&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1307/?report=reader">PubReader</a></li><li><a href="/books/NBK1307/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1307" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1307" style="display:none" title="Cite this Page"><div class="bk_tt">Ito D. BSCL2-Related Neurologic Disorders/Seipinopathy. 2005 Dec 6 [Updated 2018 May 24]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1307/pdf/Bookshelf_NBK1307.pdf">PDF version of this page</a> (419K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#spg17.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#spg17.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage">GeneReview Scope</a></li><li><a href="#spg17.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#spg17.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#spg17.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#spg17.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#spg17.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#spg17.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#spg17.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#spg17.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#spg17.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#spg17.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=26580[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">BSCL2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2617[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">GARS1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1489746" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1489746" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1489746" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1489746" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20614582" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">DNM2</i>-Related Intermediate Charcot-Marie-Tooth Neuropathy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">DNM2</i>-Related Intermediate Charcot-Marie-Tooth Neuropathy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Züchner S, Tao F. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301294" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ATP1A3-</i>Related Neurologic Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ATP1A3-</i>Related Neurologic Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Brashear A, Sweadner KJ, Cook JF, Swoboda KJ, Ozelius L. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301366" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Charcot-Marie-Tooth Neuropathy Type 2E/1F</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Charcot-Marie-Tooth Neuropathy Type 2E/1F<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">De Jonghe P, Jordanova AK. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301711" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">GDAP1</i>-Related Hereditary Motor and Sensory Neuropathy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">GDAP1</i>-Related Hereditary Motor and Sensory Neuropathy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bird TD. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23926620" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Charcot-Marie-Tooth Neuropathy Type 4H</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Charcot-Marie-Tooth Neuropathy Type 4H<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Delague V. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301484" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301484" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e041162dd21425a25a21960">BSCL2-Related Neurologic Disorders/Seipinopathy - GeneReviews®</a><div class="ralinkpop offscreen_noflow">BSCL2-Related Neurologic Disorders/Seipinopathy - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:48:18-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8A91A7E040B53100000000029000F0&amp;ncbi_session=CE8A91A7E0411611_0656SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1307%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1307&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1307/&amp;ncbi_pagename=BSCL2-Related Neurologic Disorders/Seipinopathy - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8A91A7E0411611_0656SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>